The new suit is designed to do better at keeping workers safely free of contact with contagious body fluids and will also keep workers cooler than the traditional suit. Improvements include a large visor in the hood, a rear zipper, a new doffing style that has fewer steps than that of existing equipment, and a battery-powered air source that cools the wearer by blowing air into the hood, according to the report.
The suit could be mass produced as soon as April.
The Johns Hopkins team is comprised of medical experts, engineers, students and volunteers and is supervised by the university’s Center for Bioengineering Innovation and Design and Jhpiego, a nonprofit Johns Hopkins affiliate. The project was selected for federal funding by the U.S. Agency for International Development under its program, “Fighting Ebola: A Grand Challenge for Development.”
More articles on Ebola:
Texas Health Presbyterian’s finances bounce back after Ebola crisis
The 5 states most prepared for infectious disease outbreaks
1 key take away from the Ebola outbreak: We can do better
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
